[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
November 18, 2009

Biomarkers for Prediction of Cardiovascular Events—Reply

JAMA. 2009;302(19):2089-2090. doi:10.1001/jama.2009.1638

In Reply: Dr Cook suggests that our findings differ from those of prior studies. However, the proportion of individuals correctly reclassified in some of the studies she cites was relatively modest as well. For instance, in the Physicians' Health Study, the NRI for cardiovascular events was only 3.2% with the addition of both CRP and parental history of cardiovascular disease.1 Furthermore, although Cook describes risk reclassification measures as helpful in determining whether new markers can alter clinical decisions, not all reclassification is clinically meaningful. Indeed, our findings suggest that most reclassification does not involve movement across a treatment threshold and thus may not affect decision making.

First Page Preview View Large
First page PDF preview
First page PDF preview
×